Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Journal of Crohn'S & Colitis|November 9, 2025
Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysisVirginia Solitano, Malcolm Hogan, Siddharth Singh, et al.
Journal of Crohn'S & Colitis|February 4, 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential SolutionsMathieu Uzzan, Yoram Bouhnik, Maria Abreu, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2024
Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC ConsortiumParambir S Dulai, Lauren Balmert Bonner, Charlotte Sadler, et al.
Gastroenterology|June 23, 2026
Proactive Fecal Calprotectin Home Monitoring in Ulcerative Colitis: Results of a Prospective Randomized Control TrialGregory Rosenfeld, Neeraj Narula, Yvette Leung, et al.
The American Journal of Gastroenterology|June 15, 2016
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY ConsortiumParambir S Dulai, Siddharth Singh, Xiaoqian Jiang, et al.
The American Journal of Gastroenterology|August 4, 2025
Ultra-Processed Grains and Risk of Inflammatory Bowel Disease: Results from the Prospective Urban Rural Epidemiology (PURE) StudyNeeraj Narula, Emily C L Wong, Andrew Mente, et al.
BMJ (Clinical Research Ed.)|July 15, 2021
Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort studyNeeraj Narula, Emily C L Wong, Mahshid Dehghan, et al.
The American Journal of Gastroenterology|June 28, 2018
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumNeeraj Narula, Farhad Peerani, Joseph Meserve, et al.
Pageof 19